Latest Articles

Publication Date
The top 11 dating apps for women who want real connections - Mashable

The top 11 dating apps for women who want real connections Mashable

Published: Oct. 28, 2025, 9:10 a.m.
Risk factors for postoperative recurrence of deep infiltrating endometriosis during a 6- to 12-year follow-up - Nature

Risk factors for postoperative recurrence of deep infiltrating endometriosis during a 6- to 12-year follow-up Nature

Published: Oct. 28, 2025, 8:59 a.m.
Strictly Come Dancing's Vicky Pattison makes emotional plea over health condition - Wales Online

Strictly Come Dancing's Vicky Pattison makes emotional plea over health condition Wales Online

Published: Oct. 28, 2025, 7:53 a.m.
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - BioSpace

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer BioSpace

Published: Oct. 28, 2025, 5:03 a.m.
Why the Women’s Health Space Needs to Expand Beyond Reproductive Health - MedCity News

Why the Women’s Health Space Needs to Expand Beyond Reproductive Health MedCity News

Published: Oct. 27, 2025, 10:24 p.m.
EDAP TMS S.A. Advances HIFU Treatment Study for Rectal Endometriosis - TipRanks

EDAP TMS S.A. Advances HIFU Treatment Study for Rectal Endometriosis TipRanks

Published: Oct. 27, 2025, 9:42 p.m.
Monday's Health Report: What is endometriosis and how can it affect your life? - WBRZ

Monday's Health Report: What is endometriosis and how can it affect your life? WBRZ

Published: Oct. 27, 2025, 9:02 p.m.
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - The AI Journal

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer The AI Journal

Published: Oct. 27, 2025, 7:50 p.m.
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - Yahoo Finance

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer Yahoo Finance

Published: Oct. 27, 2025, 7:33 p.m.
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - Business Wire

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer Business Wire

Published: Oct. 27, 2025, 7:33 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!